Richard Blaylock’s practice covers financing, M&A, licensing, collaboration and partnering arrangements, and intellectual property counseling for start-up and established companies whose value derives from innovative technology.
Richard is well-versed in a wide array of technologies, including those germane to both life sciences (pharmaceuticals, biologics, and diagnostics) as well as high technology (software, robotics, wireless, novel materials, and pollution control). He has counseled companies across a wide range of technologies with respect to company formation, licensing, partnering and collaborations, financing and intellectual property strategy, as well as patent, license, trademark, trade secrets and unfair competition disputes.
*****
A person listed as a contributor has spoken or otherwise participated in Federalist Society events, publications, or multimedia presentations. A person's appearance on this list does not imply any other endorsement or relationship between the person and the Federalist Society. In most cases, the biographical information on a person's "contributor" page is provided directly by the person, and the Federalist Society does not edit or otherwise endorse that information. The Federalist Society takes no position on particular legal or public policy issues. All expressions of opinion by a contributor are those of the contributor.
Deep Dive Episode 177 – Patents and Pandemics: Innovation Policy and the Patent Waiver Petition at the WTO
A Regulatory Transparency Project Teleforum
Deep Dive Episode 177 – Patents and Pandemics: Innovation Policy and the Patent Waiver Petition at the WTO
A Regulatory Transparency Project Teleforum
India and South Africa have submitted a petition to the World Trade Organization seeking a...